Simulations Plus (SLP) Reports Prelim. Q4 Rev. of $24.1M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/15/2026
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- Fed’s Warsh says central bank won’t tolerate high inflation
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- Lucid Group shares quickly cut in half on report of potential bankruptcy
- Kosovo bans Serb minister over ethnic cleansing remarks
Simulations Plus Reports Preliminary Revenues for Fourth Quarter and Fiscal Year 2017
October 3, 2017 8:30 AM EDTCompany Reports Record Fourth-Quarter and Full-Year Revenues
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical trials, today released preliminary revenues for its fiscal fourth quarter (4QFY17) and full fiscal year 2017 (FY2017) ended August 31, 2017.
Mr. John R. Kneisel, chief financial officer of Simulations Plus, stated: This quarter represents the first quarter where were reporting preliminary consolidated annual and fourth quarter revenues that include... More
